Yunosuke Yuchi
Overview
Explore the profile of Yunosuke Yuchi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
161
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yuchi Y, Suzuki R, Ishida N, Satomi S, Saito T, Teshima T, et al.
Biology (Basel)
. 2024 May;
13(5).
PMID: 38785793
Previous reports have shown that various oral pulmonary vasodilators are effective against canine pulmonary hypertension (PH). However, no studies have compared their hemodynamic effects. We aimed to compare the hemodynamic...
2.
Horikawa R, Suzuki R, Yuchi Y, Satomi S, Saito T, Teshima T, et al.
J Vet Intern Med
. 2024 Apr;
38(4):2333-2338.
PMID: 38662965
An 8-year-old Leonberger receiving immunosuppressive treatment with clinical signs of acute dyspnea, cyanosis, and difficulty standing was referred to our institution (Day 1). Treatment including oxygen, clopidogrel, and low-molecular-weight heparin...
3.
Yuchi Y, Suzuki R, Saito T, Yasumura Y, Teshima T, Matsumoto H, et al.
J Vet Intern Med
. 2023 Aug;
37(5):1656-1666.
PMID: 37593765
Background: Pulmonary hypertension (PH) secondary to respiratory disease is caused by pulmonary vascular remodeling and hypoxia. Severe PH can induce various clinical signs, including syncope and right-sided heart failure. Hypothesis/objectives:...
4.
Saito T, Suzuki R, Yuchi Y, Fukuoka H, Satomi S, Teshima T, et al.
Front Vet Sci
. 2023 Jul;
10:1191211.
PMID: 37426078
In recent years, hypertrophic cardiomyopathy (HCM) in cats has become much more common in clinical practice due to improvements in diagnostic techniques and equipment performance. One phenotype is obstructive HCM...
5.
Yuchi Y, Suzuki R, Satomi S, Saito T, Teshima T, Matsumoto H
Vet Sci
. 2023 Apr;
10(4).
PMID: 37104457
Pulmonary hypertension (PH) is a life-threatening complication in dogs with cardiopulmonary disease. Epoprostenol is an intravenous pulmonary vasodilator used to treat PH in humans; however, its efficacy in dogs remains...
6.
Akiyama N, Suzuki R, Saito T, Yuchi Y, Ukawa H, Matsumoto Y
PLoS One
. 2023 Apr;
18(4):e0283433.
PMID: 37071642
Hypertrophic cardiomyopathy (HCM) is the most common heart disease in cats with a suspected genetic origin. Previous studies have identified five HCM-associated variants in three genes (Myosin binding protein C3:...
7.
Yuchi Y, Suzuki R, Yasumura Y, Saito T, Teshima T, Matsumoto H, et al.
J Vet Intern Med
. 2023 Mar;
37(3):856-865.
PMID: 36994902
Background: Progression to combined post- and pre-capillary pulmonary hypertension (PH) provides prognostic information in human patients with post-capillary PH. Pulmonary vascular resistance estimated by echocardiography (PVRecho) is useful for the...
8.
Yasumura Y, Teshima T, Taira Y, Saito T, Yuchi Y, Suzuki R, et al.
Int J Mol Sci
. 2022 Dec;
23(23).
PMID: 36499004
Mesenchymal stem cells (MSC) are currently being investigated for their therapeutic applications in a wide range of diseases. Although many studies examined peripheral venous administration of MSC, few have investigated...
9.
Saito T, Suzuki R, Yuchi Y, Yasumura Y, Teshima T, Matsumoto H, et al.
Vet Sci
. 2022 Nov;
9(11).
PMID: 36356070
An 11-year-old intact female Papillion weighing 2.1 kg was referred to our institution with the main complaint of shallow, rapid breathing. At the first visit (day 0), although clinical signs...
10.
Suzuki R, Yuchi Y, Saito T, Yasumura Y, Teshima T, Matsumoto H, et al.
Animals (Basel)
. 2022 Aug;
12(16).
PMID: 36009668
Pulmonary hypertension (PH) is a fatal condition that affects many dogs. In humans, PH is often treated with beraprost sodium (BPS). However, the effectiveness of BPS for canine PH has...